JAMA Network podkast

JAMA Oncology : Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

24.10.2024
0:00
20:41
Do tyłu o 15 sekund
Do przodu o 15 sekund

Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.

Related Content:

Więcej odcinków z kanału "JAMA Network"